Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
    • AGM Invitations
  • inderesTV
  • Portfolio
  • Forum
  • Discovery
  • Q&A
  • About Us
    • Our Coverage
    • Team

ALK-Abelló

212.60 DKK

-0.19 %

Less than 1K followers

ALK B

NASDAQ Copenhagen

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data

Quarter data

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for ALK-Abelló

Q3/24Q4/242024Q1/25Q2/25Q3/25Q4/252025
Revenue1,313.01,499.05,537.01,522.01,527.01,530.01,733.06,312.0
EBITDA369.0281.01,363.0540.0450.0510.0482.01,982.0
EBIT306.0205.01,091.0469.0375.0423.0387.01,654.0
EBIT-%23.3 %13.7 %19.7 %30.8 %24.6 %27.6 %22.3 %26.2 %
Profit before taxes281.0198.01,057.0473.0350.0419.0393.01,635.0
Net income212.0170.0815.0354.0263.0314.0266.01,197.0
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.